Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism
Advances in Urology · 2026-01 · 2026 (1)
DOI: 10.1155/aiu/7448726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Urology, online erschienen am 15.04.2026. Verfasst von Chaojiang Chen und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The present study aims to elucidate the molecular mechanisms underlying the association between solute carrier family 6 member 1 (SLC6A1) and the aggressive progression of prostate cancer, with a particular emphasis on its relationship with mitochondrial function.
Methods
To evaluate mitochondrial function, we detected mitochondrial membrane potential, adenosine triphosphate (ATP) production, intracellular reactive oxygen species (ROS) levels, and mitochondrial morphology in prostate cancer cell lines. Western blot was used to detect apoptosis‐related proteins. Gene set enrichment analysis (GSEA) was performed using The Cancer Genome Atlas (TCGA) prostate cancer dataset.
Results
Our findings indicated that silencing of SLC6A1 decreased mitochondrial membrane potential and ATP production while increasing intracellular ROS levels, accompanied by Bax upregulation and activation of the caspase pathway. Furthermore, GSEA results suggested that low SLC6A1 expression might trigger cell apoptosis via mitochondrial disruption mediated by the interaction between potassium and calcium channels.
Conclusion
These results highlighted the role of SLC6A1 in mitochondrial dysfunction associated with cell apoptosis in prostate cancer cells. This study has provided further insights into the molecular mechanisms of advanced prostate cancer and potential therapeutic targets.
Zitieren
APA
Chen, C., Wang, R., Lin, Z., Li, J., & Zheng, Y. (2026). Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism. Advances in Urology, 2026(1). https://doi.org/10.1155/aiu/7448726
Vancouver
Chen C, Wang R, Lin Z, Li J, Zheng Y. Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism. Advances in Urology. 2026;2026(1). doi:10.1155/aiu/7448726
BibTeX
@article{Chen2026,
author = {Chen, Chaojiang and Wang, Ranting and Lin, Zhuoyuan and Li, Jianxin and Zheng, Yu},
title = {Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism},
journal = {Advances in Urology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/aiu/7448726}
}
EUVIMED